Share this bulletin
Get news bulletins by email

Bulletin Eurozone entered recession in the first quarter after downward revision to GDP »

Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Grifols S.A. ADR

NAS: GRFS

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Grifols S.A. ADR

Before the Bell

GRFS

/zigman2/quotes/208424563/composite

9.05

Change

0.00 0.00%

Volume

Volume 100

Jun 8, 2023, 4:00 a.m.

Quotes are delayed by 20 min

/zigman2/quotes/208424563/composite

Previous close

$ 9.05

Change

+0.20 +2.26%

Day low

Day high

$8.94

$9.14

Open: 9.01

52 week low

52 week high

$5.71

$13.10

Market cap

$7.62B

Average volume

793,909

P/E ratio

27.63

Rev. per Employee

$242,083

EPS

0.33

Dividend

N/A

Div yield

N/A

Ex dividend date

6/3/21

Compare:

Indexes

Dow(INDU) INDU
Nasdaq (COMP) COMP
S&P 500 (SPX) SPX
Global Dow (GDOW) GDOW

/news/latest/company/us/grfs

MarketWatch News on GRFS

Now Is the Time to Invest Overseas

9:31 p.m. April 7, 2023

- Barron's Online
These Undervalued European Stocks Are Set to Beat Pre-Covid Earnings

5:00 a.m. March 1, 2021

- Barron's Online
Here are the European Stocks With Pricing Power to Benefit When Pandemic Ends, Says Citigroup

9:53 p.m. Jan. 20, 2021

- Barron's Online
Coronavirus Toll Surges in Spain

12:53 p.m. March 21, 2020

- Barron's Online
These European companies benefit from high health-care prices in the U.S.

4:34 p.m. June 27, 2019

- Philip van Doorn
Rigel Pharmaceuticals stock up 9% after announcing licensing agreement with Grifols

8:51 a.m. Jan. 23, 2019

- Sarah Toy
Hologic to sell stake in blood screening unit for $1.85 bln

5:43 p.m. Dec. 14, 2016

- Sue Chang
Seek cover in European stocks if Fed hikes rates, says Deutsche Bank

10:39 a.m. Sept. 17, 2015

- Carla Mozee
15 European companies benefiting from a weak euro

6:55 a.m. Jan. 8, 2015

- Philip van Doorn
Ownership Roundup: Buffett and the Hedge Funds at 3Q

6:34 p.m. Nov. 17, 2014

- Barrons Blogs
Charting a garden-variety pullback

11:54 a.m. June 12, 2014

- Michael Ashbaugh
Stocks Flat as Sellers Sidestep Fed Moves

2:00 p.m. Sept. 24, 2012

- Barron's Online

Analyst Ratings

Goldman Sachs: Time To Buy Carlisle Companies And Grifols

8:17 a.m. May 18, 2015

- Benzinga.com
UPDATE: Morgan Stanley Reiterates On Grifols SA Barcelona On Initial Analyst Day Review

7:55 a.m. June 5, 2014

- Benzinga.com

/news/nonmarketwatch/company/us/grfs

Other News on GRFS

Soditic Asset Management LLP Cuts Portfolio Down to Size in 4th Quarter

1:00 p.m. Feb. 9, 2023

- GuruFocus.com
Lapides Asset Management, LLC Buys 2, Sells 3 in 3rd Quarter

1:00 p.m. Oct. 27, 2022

- GuruFocus.com
Mexicans Can Cross U.S. Border to Get Paid for Plasma, Court Rules

2:33 a.m. Sept. 20, 2022

- The Wall Street Journal Interactive Edition
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

6:20 a.m. Sept. 14, 2022

- Zacks.com
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

6:20 a.m. Sept. 9, 2022

- Zacks.com
5 High-Performing Stocks in Historical Low PS Model Portfolio

5:01 p.m. July 6, 2022

- GuruFocus.com
Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

8:05 a.m. May 26, 2022

- Motley Fool
Analysts Tab Veeva Systems as a Top Value Pick

4:23 p.m. May 25, 2022

- GuruFocus.com
The Best Healthcare Dividend Stock on the Planet for Generating Passive Income

5:52 a.m. April 29, 2022

- Motley Fool

/news/pressrelease/company/us/grfs

Press Releases on GRFS

Grifols Launches AlphaID(TM) At Home, Enabling U.S. Consumers to Self-Screen for Genetic COPD

8:30 a.m. May 11, 2023

- GlobeNewswire
Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023

10:30 a.m. April 18, 2023

- PR Newswire - PRF
Selagine Enters into a Collaborative Agreement with Grifols for Development and Commercialization of Immunoglobulin Eye Drops for Treating Dry Eye Disease

8:00 a.m. March 6, 2023

- PR Newswire - PRF
Grifols receives FDA clearance for AlphaID(TM) At Home, the first free service for U.S. consumers to determine their risk for alpha-1

9:01 a.m. Nov. 3, 2022

- PR Newswire - PRF
Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson

12:52 p.m. Oct. 3, 2022

- PR Newswire - PRF
GigaGen Awarded Contract by U.S. Department of Defense to Discover Synthetic Human Antibody Treatments for High-Priority Toxins and Pathogens

10:29 a.m. Sept. 15, 2022

- GlobeNewswire
Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada

12:06 p.m. Sept. 7, 2022

- PR Newswire - PRF
GigaGen Publishes Research Showcasing First-Ever Clinical GMP Manufacturing and IND-Enabling Studies for its New Class of Drugs, Recombinant Polyclonal Antibodies

10:48 a.m. July 28, 2022

- GlobeNewswire
Bronchiectasis Treatment Market 2021 Segmented by Product, Application, Key Players and Regional Analysis to 2031

5:37 a.m. July 21, 2021

- marketresearch.biz
Nucleic Acid Amplification Testing Market 2021 Growth Probability, Key Vendors and Future Scenario (PDF Report)|Becton, Dickinson and Company, Hoffmann-La Roche AG

9:22 a.m. April 29, 2021

- marketresearch.biz
Coating Additives Market 2021 SWOT Analysis (PDF Report) & Key Business Strategies by Leading Players |Akzo Nobel N.V, Arkema S.A, Ashland Inc.

6:18 a.m. April 9, 2021

- marketresearch.biz
Mass Notification Systems Market 2021 Assessment, Revenue, Recommendations, Challenges|Blackberry AtHoc Inc, Everbridge Inc, Eaton Corporation Plc.

7:29 a.m. April 8, 2021

- marketresearch.biz
Hemophilia Treatment Market SWOT Analysis (PDF Report) & Key Business Strategies by Leading Players |Baxter International Inc, Grifols SA, CSL Ltd

5:19 a.m. April 7, 2021

- marketresearch.biz
Learn details of the Advances in Air Freight Transportation Services Market Forecast and Segments (2021 - 2026): Marketdesk

1:46 a.m. March 16, 2021

- marketresearch.biz
Global Immunoglobulin Products Market Key Drivers, Restraints, and Opportunities, forecast to 2021-2029 | With Key Players: Grifols SA , Abeona Therapeutics , CSL Behring, Anthera Pharmaceuticals Market.biz

7:30 a.m. March 9, 2021

- marketresearch.biz
Intravenous Immunoglobulin Market up-to-date Analysis of Industry Trends 2021- 2030 | Hualan Biological Engineering Inc, Omrix Biopharmaceuticals Ltd

3:36 a.m. Jan. 21, 2021

- marketresearch.biz

Rates »

Mortgage Equity Savings Auto

National averages from Bankrate.com

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Grifols S.A. ADR

MarketWatch News on GRFS

Analyst Ratings

Other News on GRFS

Press Releases on GRFS

Rates »

Latest News

dow

nasdaq

s&p 500

Kiosk